检索

Clinical experience of long-term observation of the efficacy of a fixed combination of insulin glargine and GLP-1RA lixisenatide in patients with type 2 diabetes mellitus who did not reach the target glycemia values with the use of oral antidiabetic drugs

Mkrtumyan A., Markova T.

(Rus)

The many faces of vitamin D

Verbovoy A., Dolgikh Y., Verbovaya N.

(Rus)

Do we know everything about the possibilities of metformin in the treatment of type 2 diabetes mellitus? Which of its combinations is the most studied, effective and available for the patient in the real practice of the endocrinologist?

Biryukova E., Solovyova I.

(Rus)

Insulin detemir and its place in the diabetes treatment: results of 15-year use

Girsh Y.

(Rus)

编号 11 (2018)

Problem of detection and pharmacological correction of anxious and depressive disorders in patients with type 2 diabetes mellitus

Sorokina Y., Zanozin A., Zanozina O., Runov G.

(Rus)

编号 4 (2018)

NEW ONCE-WEEKLY GLP-1 RECEPTOR AGONIST - A QUALITATIVE LEAP IN MANAGEMENT OF TYPE 2 DIABETES MELLITUS

Demidova T.

(Rus)

编号 16 (2017)

Diabetic distal polyneuropathy: the principles of diagnostics and therapy

Komelyagina E., Antsiferov M.

(Rus)

编号 5 (2017)

ELDERLY PATIENT WITH TYPE 2 DIABETES MELLITUS: FOCUS ON ALOGLIPTIN

Petunina N., Terekhova A.

(Rus)

编号 16 (2016)

Effect of glucagon-like peptide-1 receptor agonist on cardiovascular risk markers in patients with type 2 diabetes mellitus

Mkrtumyan A., Podachina S., Sviridova M.

(Rus)

编号 5 (2016)

EFFICIENCY OF MULTICOMPONENT THERAPY IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS (CLINICAL CASE)

Koteshkova O., Molina L.

(Rus)

编号 1S (2015)

Kombinirovannaya tsitostaticheskaya i angioprotektivnaya terapiya bol'nykh psoriazom

Bakulev A., Utts S., Shtoda Y.

(Rus)

编号 13 (2015)

Sakharosnizhayushchaya terapiya i serdechno- sosudistaya bezopasnost'

Pashentseva A., Verbovoy A.

(Rus)

编号 5 (2015)

Alogliptin - effektivnyy i bezopasnyy ingibitor dipeptidilpeptidazy-4 v terapii bol'nykh sakharnym diabetom 2 tipa

Mkrtumyan A.

(Rus)

编号 16 (2014)

Issledovanie ORIGIN (Outcome Reduction with Initial Glargine INtervention) 2 goda spustya: chto novogo?

Glinkina I.

(Rus)

编号 7 (2014)

FAKTORY RISKA RAZVITIYa OSTEOPOROZA

Akimova D.

(Rus)

编号 5 (2014)

ISSLEDOVANIE SAVOR: OTKRYTIE NOVOY EPOKhI BEZOPASNOY FARMAKOTERAPII SAKhARNOGO DIABETA 2 TIPA

Yuryatin A.

(Rus)

编号 16 (2013)

Dolgosrochnaya bezopasnost' i effektivnost' insulina aspart u patsientov s sakharnym diabetom 1 tipa

Antsiferov M.

(Rus)

编号 6 (2013)

GIPOGLIKEMII V PATOGENEZE SERDEChNO-SOSUDISTOGO RISKA

Ruyatkina L., Ruyatkin D., Berezovskaya G.

(Rus)

编号 5 (2013)

SOVETNIK BOLYuSA": EFFEKTIVNOE I BEZOPASNOE UPRAVLENIE POSTPRANDIAL'NOY GLIKEMIEY U PATsIENTOV NA POMPOVOY INSULINOTERAPII

Ametov A., Valitov B., Chernikova N., Antsiferov M.

(Rus)

编号 16 (2012)

Naznachenie sakharosnizhayushchego preparata patsientu - chto eshche neobkhodimo, krome retsepta?

Antsiferov M., Galstyan G.

(Rus)

编号 16 (2012)

Pompovaya insulinoterapiya: novye tekhnologii v sovremennoy klinicheskoy praktike

Ametov A., Valitov B., Chernikova N., Antsiferov M.

(Rus)

编号 7 (2012)

PAINFUL DIABETIC POLYNEUROPATHY

Strokov I., Strokov I.

编号 3 (2012)

SULFONYLUREAS IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS TODAY. IS THERE A PROSPECT?

Kononenko I., Smirnova O., Smirnova O., Kononenko I.

编号 16 (2011)

Insulin pump - advanced menu of experienced user

Arbatskaya N., Arbatsraya N.

编号 10 (2011)

IRBESARTAN I NEFROPROTEKTsIYa: VLIYaNIE NA TUBULOINTERSTITsIAL'NUYu TKAN' I FUNKTsIYu POChKI V TsELOM

Arutyunov G., Oganezova L.

编号 3 (2011)

COMBINED THERAPY OF TYPE 2 DIABETES MELLITUS

Petunina N., Trukhina L., Petunina N., Truhina L.

编号 16 (2010)

ROLE OF SPECIALIZED NUTRITION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: CLINICAL EXPERIENCE OF USING OF GLUCERNA SR

Antsiferov M., Morgunov L., Antsiferov M., Morgunov L.

编号 8 (2010)

ADIPONECTIN AND C-REACTIVE PROTEIN AS FACTORS OF CARDIOVASCULAR RISK IN MEN WITH TYPE 2 DIABETES MELLITUS

Morkovskikh N., Morkovskikh N.

编号 3 (2010)

New possibilities for diabetic peripheral neuropathy treatment

Komelyagina E., Antsiferov M., Komelyagina E., Antsiferov M.

编号 17 (2009)

SOVREMENNYY VZGLYaD NA INSULINOTERAPIYu U BOL'NYKh SAKhARNYM DIABETOM

Ametov A., Karpova E.

编号 17 (2009)

MEKhANIZM DEYSTVIYa I KLINIChESKOE PRIMENENIE METFORMINA (SIOFOR®): OBZOR LITERATURY

Demidova I., Gorokhova T.

编号 3 (2009)

Insulin pump therapy - a way to achieve clinical and metabolic compensation of the disease in children and adolescents with type 1 diabetes mellitus

Petryaykina E., Dukhareva O., Rybkina I., Pronina E., Mikhaylova T., Garyaeva I., Mandzhieva E., Petryaikina E., Duchareva O., Ryibkina I., Pronina E., Michailova T., Garyaeva I., Mandjieva E.

卷 29, 编号 11/12 (2022)

Place of GLP-1 receptor antagonists and SGLT-2 inhibitors in modern therapy of type 2 diabetes mellitus

Antsiferov M., Koteshkova O., Dukhareva O., Demidov N., Novikova M.

(Rus)

卷 29, 编号 4 (2022)

The use of the last generation insulin analogues for the control of diabetes mellitus in real clinical practice

Koteshkova O., Dukhareva O., Demidov N., Antsiferov M.

(Rus)

卷 28, 编号 12 (2021)

Obesity: an invisible disease

Verbovoy A., Dolgikh Y., Verbovaya N., Lomonova T.

(Rus)

Ipragliflozin in the treatment of comorbid patients with type 2 diabetes mellitus

Chernikova N., Knyshenko O., Ivanova L.

(Rus)

Gestational diabetes mellitus: prevention of reproductive loss

Glavnova O., Shelygin M., Salukhova A.

(Rus)

卷 27, 编号 12 (2020)

Possibilities of using taurine in the treatment of psychovegetative disorders in patients with type 2 diabetes mellitus

Demicheva T.

(Rus)

Modern topical treatment of psoriasis in diabetic patients

Lykova S., Nemchaninova O., Svechnikova E., Morzhanayeva M.

(Rus)

卷 26, 编号 14 (2019)

Early pathogenetic combined therapy of sugar diabetes type 2: focus on insulin resistance

Ametov A., Tertychnaya E.

(Rus)

The place of glyflozins in the management of type 2 diabetes mellitus

Sharonova L., Verbovoy A.

(Rus)

Diabetic autonomic neuropathy: problems of diagnosis and therapy

Kurnikova I., Yurovsky A.

(Rus)

编号 11 (2018)

Features of glycemic control in patients with type 2 diabetes mellitus and chronic heart failure

Demidova T., Titova V.

(Rus)

编号 2 (2018)

Efficiency of different schemes of antihelicbacter therapy in patients with chronic gastroduodenal diseases and type 2 diabetes mellitus

Fedorchenko Y., Martynyuk M.

(Rus)

编号 16 (2017)

Fixed-dose combinations in the therapy of type 2 diabetes mellitus: the way to achieving good glycemic control

Biryukova E.

(Rus)

编号 5 (2017)

ANGIOTENSIN II RECEPTOR BLOCKERS AND ENDOTHELIAL DYSFUNCTION: FOCUS ON NEPHROCEREBRAL INTERACTIONS

Murkamilov I., Aytbaev K., Yusupov F.

(Rus)

编号 16 (2016)

Modern approaches to the treatment of patients with type 2 diabetes mellitus

Antsiferov M., Fadeev V., Morgunova T.

(Rus)

编号 5 (2016)

PATHOGENETIC THERAPY OF DIABETIC POLYNEUROPATHY

Badalyan O., Savenkov A.

(Rus)

编号 17 (2015)

Vozmozhnosti primeneniya insulina detemir pri lechenii sakharnogo diabeta u beremennykh: dokazannye preimushchestva i perspektivy ispol'zovaniya

Ruyatkina L., Sorokin M.

(Rus)

编号 10 (2015)

Vliyanie Aktovegina na reparatsiyu khronicheskikh ran razlichnoy etiologii

Dibirov M., Gadzhimuradov R., Khalidov O., Kakubava M., Polyanskiy M.

(Rus)

编号 5 (2015)

Ingibitory SGLT-2: farmakologicheskaya glyukozuriya kak novyy podkhod v upravlenii SD 2 tipa

Demidova T.

(Rus)

编号 16 (2014)

Leptin i gormonal'no-metabolicheskie pokazateli u bol'nykh bronkhial'noy astmoy i pri ee sochetanii s sakharnym diabetom 2 tipa

Verbovoy A., Sharonova L., Akhmerova R.

(Rus)

编号 5 (2014)

OSOBENNOSTI SAKhAROSNIZhAYuShchEY TERAPII VO VREMYa BEREMENNOSTI

Arbatskaya N.

(Rus)

编号 5 (2014)

VLIYaNIE KOMBINATsII METFORMINA I VILDAGLIPTINA NA POKAZATELI UGLEVODNOGO I ZhIROVOGO OBMENOV U BOL'NYKh SAKhARNYM DIABETOM 2 TIPA

Abaeva M., Nazhmutdinova P., Ametov A.

(Rus)

编号 16 (2013)

Bazal'naya insulinoterapiya: opyt klinicheskoy praktiki

Chernikova N., Ametov A., Antsiferov M.

(Rus)

编号 5 (2013)

KLINIChESKIE PREIMUShchESTVA PERVOGO ANALOGA ChELOVEChESKOGO GPP-1 LIRAGLUTIDA PRI LEChENII BOL'NYKh SAKhARNYM DIABETOM 2 TIPA

Demidova I.

(Rus)

编号 5 (2013)

SOSTOYaNIE KOSTNOY TKANI PRI SAKhARNOM DIABETE 2 TIPA

Ruyatkina L., Lomova A., Ruyatkin D.

(Rus)

编号 16 (2012)

Khronicheskaya serdechnaya nedostatochnost' u bol'nykh sakharnym diabetom: sovremennye predstavleniya

Ettinger O.

(Rus)

编号 16 (2012)

Nevropatiya i prediabet: eti chasy nachinayut tikat' rano

Ametov A., Lysenko M.

(Rus)

编号 7 (2012)

DIPEPTIDYL PEPTIDASE-4 INHIBITORS IN COMBINATION WITH METFORMIN: EXPERIENCE OF USE OF GALVUS MET IN REAL-LIFE CLINICAL PRACTICE IN MOSCOW

Antsiferov M., Antsiferov M.

编号 3 (2012)

APPLICATION OF VILDAGLIPTIN IN COMBINATION WITH INSULIN IN TYPE 2 DIABETES MELLITUS

Antsiferov M., Antsiferov M.

编号 16 (2011)

Galvus and Galvus Met in treatment of elderly patients with type 2 diabetes mellitu

Antsiferov M., Antciferov M.

编号 5 (2011)

CLINICAL AND METABOLIC EFFICIENCY OF DRUG DIBIKOR IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

Severina T., Popkova E., Trel'skaya N., Emel'yanov V., Severina T., Popkova Y., Trelskaya N., Yemelyanov V.

编号 3 (2011)

INITIATION OF THERAPY WITH INSULIN PUMP IN PATIENTS WITH TYPE 1 DIABETES

Antsiferov M., Koteshkova O., Kleymenova S., Antsiferov M., Koteshkova O., Kleimenko S.

编号 16 (2010)

WHEN TO BEGIN COMBINED THERAPY OF TYPE 2 DIABETES MELLITUS

Petunina N., Petunina N.

编号 7 (2010)

ANTIOXIDANT THERAPY OF DIABETIC POLYNEUROPATHY

Tabeeva G., Azimova Y., Tabeeva G., Azimova Y.

编号 3 (2010)

Advance - movement forward

Petunina N., Petunina N.

编号 17 (2009)

OPTIMIZATsIYa INSULINOTERAPII SAKhARNOGO DIABETA TIPA 1 V PERIOD BEREMENNOSTI

Demidova I., Mel'nikova E., Arbatskaya N., Ignatova N.

编号 15 (2009)

Insulin resistance and heart diseases: is there a relationship?

Drapkina O., Smirin V., Ivashkin V., Drapkina O., Smirin V., Ivaschkin V.

编号 3 (2009)

Possibilities of insulin glargine (Lantus ®) use for treatment of type 2 diabetes mellitus in the outpatient endocrinology services: an analysis of the register LAUREL

Antsiferov M., Petraneva E., Anciferov M., Petraneva E.

卷 29, 编号 11/12 (2022)

Cardiovascular outcomes during treatment with dipeptidyl peptidase-4 inhibitors depending on renal function and combination with metformin: a systematic review

Petunina N., Martirosyan N., Valeeva F.

(Rus)

卷 29, 编号 4 (2022)

Application of the diabetes screening questionnaire in patients with psoriasis

Morzhanaeva M., Svechnikova E., Shchepkina E., Kuznetsov A.

(Rus)

卷 28, 编号 12 (2021)

Differentiated approach to metformin therapy in newly diagnosed type 2 diabetes mellitus from the perspective of pharmacogenetics

Shorokhova P., Baranov V.

(Rus)

Experience of insulin degludec treatment using constant glucose monitoring system (CGMS)

Smirnova E.

(Rus)

Practical aspects of the use of semaglutide (Ozempic®) in real clinical practice

Antsiferov M., Zilov A., Koteshkova O., Demidov N.

(Rus)

卷 27, 编号 12 (2020)

Improvement of the efficacy of conservative treatment of rhinosinusitis and otitis media in patients with type 2 diabetes mellitus: an open-label prospective randomized clinical trial

Shkurova N., Baranova N., Fedin A.

(Rus)

Cranial neuropathy as a complication of diabetes mellitus

Maksimova M., Stepanchenko O.

(Rus)

卷 26, 编号 14 (2019)

Experience in the integrated use of organizational approaches and clinical tools to achieve glycemic control goals

Antsiferov M., Demidov N.

(Rus)

Potential drug interactions of oral hypoglycemic drugs that increase the risk of hypoglycemia

Pereverzev A., Ostroumova O., Tkacheva O.

(Rus)